SEC ownership of Quantum Biopharma Ltd.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001771885.

Comparable stake leader

Malone Wealth Ventures LLC

Disclosed value leader

Malone Wealth Ventures LLC

Comparable rows

28/28

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
28 of 28
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Malone Wealth Ventures LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001771885
Issuer location
Toronto

Ownership snapshot

Top shareholders of Quantum Biopharma Ltd. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Malone Wealth Ventures LLC
Disclosed value leader
Malone Wealth Ventures LLC
Comparable rows
28/28
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 9.8% 13D/G row: Malone Wealth Ventures LLC Showing 1-8 of 28 holder rows.

Quick read

Malone Wealth Ventures LLC leads the comparable SEC ownership view at 9.8%.

28 of 28 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Malone Wealth Ventures LLC's linked filing trail.
Comparable ownership Top 5
Malone Wealth Ventures LLC 9.8%
AdvisorShares Trust 5.3%
AdvisorShares Investments LLC 5.3%
JANE STREET GROUP, LLC 1.3%
Platform Technology Partners 1.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 28 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Malone Wealth Ventures LLC
13D/G
9.8%
$2,754,262
375,752 shares
-$3,327,659 03 Feb 2026
AdvisorShares Trust
13D/G
5.3%
$814,256
203,564 shares
$0 30 Jun 2026
AdvisorShares Investments LLC
13F
Company
13F
5.3%
$736,902
203,564 shares
30 Jun 2026
JANE STREET GROUP, LLC
13F
Company
13F
1.3%
$175,045
48,355 shares
30 Jun 2026
Platform Technology Partners
13F
Company
13F
1.1%
$148,840
41,116 shares
30 Jun 2026
UBS Group AG
13F
Company
13F
0.87%
$120,926
33,405 shares
30 Jun 2026
Steward Partners Investment Advisory, LLC
13F
Company
13F
0.73%
$100,929
27,881 shares
30 Jun 2026
CITADEL ADVISORS LLC
13F
Company
13F
0.42%
$57,424
15,863 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Quantum Biopharma Ltd.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .